Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

More than one way to die: apoptosis, necrosis and reactive oxygen damage

Abstract

Cell death is an essential phenomenon in normal development and homeostasis, but also plays a crucial role in various pathologies. Our understanding of the molecular mechanisms involved has increased exponentially, although it is still far from complete. The morphological features of a cell dying either by apoptosis or by necrosis are remarkably conserved for quite different cell types derived from lower or higher organisms. At the molecular level, several gene products play a similar, crucial role in a major cell death pathway in a worm and in man. However, one should not oversimplify. It is now evident that there are multiple pathways leading to cell death, and some cells may have the required components for one pathway, but not for another, or contain endogenous inhibitors which preclude a particular pathway. Furthermore, different pathways can co-exist in the same cell and are switched on by specific stimuli. Apoptotic cell death, reported to be non-inflammatory, and necrotic cell death, which may be inflammatory, are two extremes, while the real situation is usually more complex. We here review the distinguishing features of the various cell death pathways: caspases (cysteine proteases cleaving after particular aspartate residues), mitochondria and/or reactive oxygen species are often, but not always, key components. As these various caspase-dependent and caspase-independent cell death pathways are becoming better characterized, we may learn to differentiate them, fill in the many gaps in our understanding, and perhaps exploit the knowledge acquired for clinical benefit.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

Abbreviations

BHA:

butylated hydroxyanisole

cyt c:

cytochrome c

CD95L:

CD95 ligand

DD:

death domain

DED:

death effector domain

DEM:

diethylmaleate

MAPKKK:

MAP kinase kinase kinase

MnSOD:

manganese superoxide dismutase

NAC:

N-acetylcysteine

PCD:

programmed cell death

PDTC:

pyrrolidine-dithiocarbamate

ROS:

reactive oxygen species

TNF:

tumour necrosis factor

TNF-RI:

TNF receptor I

zVAD-fmk:

benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone

References

  • Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J and Krönke M. . 1996 Cell 86: 937–947.

  • Ashkenazi A and Dixit VM. . 1998 Science 281: 1305–1308.

  • Ã…slund F and Beckwith J. . 1999 Cell 96: 751–753.

  • Baker A, Payne CM, Briehl MM and Powis G. . 1997 Cancer Res. 57: 5162–5167.

  • Baker SJ and Reddy EP. . 1998 Oncogene 17: 3261–3270.

  • Banki K, Hutter E, Gonchoroff NJ and Perl A. . 1999 J. Immunol. 162: 1466–1479.

  • Bauer MKA, Vogt M, Los M, Siegel J, Wesselborg S and Schulze-Osthoff K. . 1998 J. Biol. Chem. 273: 8048–8055.

  • Belaud-Rotureau M-A, Lacombe F, Durrieu F, Vial J-P, Lacoste L, Bernard P and Belloc F. . 1999 Cell Death Differ. 6: 788–795.

  • Berkow RL, Wang D, Larrick JW, Dodson RW and Howard TH. . 1987 J. Immunol. 139: 3783–3791.

  • Boldin MP, Goncharov TM, Goltsev YV and Wallach D. . 1996 Cell 85: 803–815.

  • Borner C and Monney L. . 1999 Cell Death Differ. 6: 497–507.

  • Boveris A and Chance B. . 1973 Biochem. J. 134: 707–716.

  • Brekke O-L, Shalaby MR, Sundan A, Espevik T and Bjerve KS. . 1992 Cytokine 4: 269–280.

  • Carswell EA, Old LJ, Kassel RL, Green S, Fiore N and Williamson B. . 1975 Proc. Natl. Acad. Sci. USA 72: 3666–3670.

  • Castagne V and Clarke PGH. . 1996 Proc. Royal Soc. London 263: B1193–B1197.

  • Chang HY, Nishitoh H, Yang X, Ichijo H and Baltimore D. . 1998 Science 281: 1860–1863.

  • Chang HY, Yang X and Baltimore D. . 1999 Proc. Natl. Acad. Sci. USA 96: 1252–1256.

  • Chautan M, Chazal G, Cecconi F, Gruss P and Golstein P. . 1999 Curr. Biol. 9: 967–970.

  • Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K and Hardwick JM. . 1997 Science 278: 1966–1968.

  • Chen ZH, Seimiya H, Naito M, Mashima T, Kizaki A, Dan S, Imaizumi M, Ichijo H, Miyazono K and Tsuruo T. . 1999 Oncogene 18: 173–180.

  • Daemen MARC, van't Veer C, Denecker G, Heemskerk VH, Wolfs TGAM, Clauss M, Vandenabeele P and Buurman WA. . 1999 J. Clin. Invest. 104: 541–549.

  • Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B and Martinou J-C. . 1999 J. Cell Biol. 144: 891–901.

  • De Valck D, Jin D-Y, Heyninck K, Van de Craen M, Contreras R, Fiers W, Jeang K-T and Beyaert R. . 1999 Oncogene 18: 4182–4190.

  • De Valck D, Vercammen D, Fiers W and Beyaert R. . 1998 J. Cell. Biochem. 71: 392–399.

  • De Vos K, Goossens V, Boone E, Vercammen D, Vancompernolle K, Vandenabeele P, Haegeman G, Fiers W and Grooten J. . 1998 J. Biol. Chem. 273: 9673–9680.

  • Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE and Wyllie AH. . 1992 Biochim. Biophys. Acta 1133: 275–285.

  • Dragovich T, Rudin CM and Thompson CB. . 1998 Oncogene 17: 3207–3213.

  • Dusi S, Della Bianca V, Donini M, Nadalini KA and Rossi F. . 1996 J. Immunol. 157: 4615–4623.

  • Eddy LJ, Goeddel DV and Wong GH. . 1992 Biochem. Biophys. Res. Commun. 184: 1056–1059.

  • Eguchi Y, Shimizu S and Tsujimoto Y. . 1997 Cancer Res. 57: 1835–1840.

  • Ellerby LM, Ellerby HM, Park SM, Holleran AL, Murphy AN, Fiskum G, Kane DJ, Testa MP, Kayalar C and Bredesen DE. . 1996 J. Neurochem. 67: 1259–1267.

  • Ellis HM and Horvitz HR. . 1986 Cell 44: 817–829.

  • Espevik T and Nissen-Meyer J. . 1986 J. Immunol. Methods 95: 99–105.

  • Faris M, Kokot N, Latinis K, Kasibhatla S, Green DR, Koretzky GA and Nel A. . 1998 J. Immunol. 160: 134–144.

  • Fiers W, Brouckaert P, Devos R, Fransen L, Leroux-Roels G, Remaut E, Suffys P, Tavernier J, Van der Heyden J and Van Roy F. . 1986 Cold Spring Harbor Symp. Quant. Biol. 51: 587–595.

  • Friedlander RM, Brown RH, Gagliardini V, Wang J and Yuan J. . 1997a Nature 388: 31.

  • Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, Fishman MC, Greenberg AH, Moskowitz MA and Yuan J. . 1997b J. Exp. Med. 185: 933–940.

  • Friedlander RM and Yuan J. . 1998 Cell Death Differ. 5: 823–831.

  • Geier A, Weiss C, Beery R, Haimsohn M, Hemi R, Malik Z and Karasik A. . 1995 J. Cell Physiol. 163: 570–576.

  • Goossens V, De Vos K, Vercammen D, Steemans M, Vancompernolle K, Fiers W, Vandenabeele P and Grooten J. . 1999 BioFactors 10, in press.

  • Goossens V, Grooten J, De Vos K and Fiers W. . 1995 Proc. Natl. Acad. Sci. USA 92: 8115–8119.

  • Gotoh Y and Cooper JA. . 1998 J. Biol. Chem. 273: 17477–17482.

  • Green DR and Reed JC. . 1998 Science 281: 1309–1312.

  • Greenlund LJ, Deckwerth TL and Johnson Jr EM. . 1995 Neuron 14: 303–315.

  • Grooten J, Goossens V, Vanhaesebroeck B and Fiers W. . 1993 Cytokine 5: 546–555.

  • Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW. . 1998 Cell 94: 339–352.

  • Hall SS. . 1997 A Commotion in the Blood, New York, H. Holt & Co.

    Google Scholar 

  • Hammond EM, Brunet CL, Johnson GD, Parkhill J, Milner AE, Brady G, Gregory CD and Grand RJA. . 1998 FEBS Lett. 425: 391–395.

  • Hampton MB and Orrenius S. . 1998 Toxicol. Lett. 102–103: 355–358.

  • Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J and Moskowitz MA. . 1997 Proc. Natl. Acad. Sci. USA 94: 2007–2012.

  • Higuchi M, Aggarwal BB and Yeh ETH. . 1997 J. Clin. Invest. 99: 1751–1758.

  • Higuchi M, Proske RJ and Yeh ETH. . 1998 Oncogene 17: 2515–2524.

  • Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J and Marrack PC. . 1999 Immunity 10: 735–744.

  • Hildt E and Oess S. . 1999 J. Exp. Med. 189: 1707–1714.

  • Hirose K, Longo DL, Oppenheim JJ and Matsushima K. . 1993 FASEB J. 7: 361–368.

  • Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL and Korsmeyer SJ. . 1993 Cell 75: 241–251.

  • Hofmann K and Dixit VM. . 1998 Trends Biochem. Sci. 23: 374–377.

  • Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J and Miyazaki J. . 1998 J. Exp. Med. 188: 1445–1451.

  • Hu Y, Benedict MA, Wu D, Inohara N and Núñez G. . 1998 Proc. Natl. Acad. Sci. USA 95: 4386–4391.

  • Hug H, Strand S, Grambihler A, Galle J, Hack V, Stremmel W, Krammer PH and Galle PR. . 1997 J. Biol. Chem. 272: 28191–28193.

  • Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y. . 1997 Science 275: 90–94.

  • Imai Y, Kimura T, Murakami A, Yajima N, Sakamaki K and Yonehara S. . 1999 Nature 398: 777–785.

  • Jacobson MD and Raff MC. . 1995 Nature 374: 814–816.

  • Jänicke RU, Sprengart ML, Wati MR and Porter AG. . 1998 J. Biol. Chem. 273: 9357–9360.

  • Jiang Y, Woronicz JD, Liu W and Goeddel DV. . 1999 Science 283: 543–546.

  • Jones PL, Ping D and Boss JM. . 1997 Mol. Cell. Biol. 17: 6970–6981.

  • Kane DJ, Ord T, Anton R and Bredesen DE. . 1995 J. Neurosci. Res. 40: 269–275.

  • Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Örd T and Bredesen DE. . 1993 Science 262: 1274–1277.

  • Kawaguchi T, Takeyasu A, Matsunobu K, Uda T, Ishizawa M, Suzuki K, Nishiura T, Ishikawa M and Taniguchi N. . 1990 Biochem. Biophys. Res. Commun. 171: 1378–1386.

  • Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y and Nagata S. . 1998 J. Cell Biol. 143: 1353–1360.

  • Kitanaka C and Kuchino Y. . 1999 Cell Death Differ. 6: 508–515.

  • Koonin EV, Aravind L, Hofmann K, Tschopp J and Dixit VM. . 1999 Nature 401: 662–663.

  • Krammer PH. . 1999 Adv. Immunol. 71: 163–210.

  • Lancaster Jr JR, Laster SM and Gooding LR. . 1989 FEBS Lett. 248: 169–174.

  • Le-Niculescu H, Bonfoco E, Kasuya Y, Claret F-X, Green DR and Karin M. . 1999 Mol. Cell. Biol. 19: 751–763.

  • Leist M, Single B, Castoldi AF, Kühnle S and Nicotera P. . 1997 J. Exp. Med. 185: 1481–1486.

  • Lelli JL, Becks LL, Dabrowska MI and Hinshaw DB. . 1998 Free Rad. Biol. Med. 25: 694–702.

  • Li H, Zhu H, Xu C and Yuan J. . 1998 Cell 94: 491–501.

  • Li JJ and Oberley LW. . 1997 Cancer Res. 57: 1991–1998.

  • Lieberthal W, Menza SA and Levine JS. . 1998 Am. J. Physiol. 43: F315–F327.

  • Longo VD, Ellerby LM, Bredesen DE, Valentine JS and Gralla EB. . 1997 J. Cell Biol. 137: 1581–1588.

  • Lorenzo HK, Susin SA, Penninger J and Kroemer G. . 1999 Cell Death Differ. 6: 516–524.

  • Los M, Wesselborg S and Schulze-Osthoff K. . 1999 Immunity 10: 629–639.

  • Luo X, Budihardjo I, Zou H, Slaughter C and Wang X. . 1998 Cell 94: 481–490.

  • Madeo F, Fröhlich E, Ligr M, Grey M, Sigrist SJ, Wolf DH and Fröhlich K-U. . 1999 J. Cell Biol. 145: 757–767.

  • Manna SK and Aggarwal BB. . 1999 J. Immunol. 162: 1510–1518.

  • Mannick JB, Hausladen A, Liu L, Hess DT, Zeng M, Miao QX, Kane LS, Gow AJ and Stamler JS. . 1999 Science 284: 651–654.

  • Martinou J-C. . 1999 Nature 399: 411–412.

  • Matthews N. . 1983 Br. J. Cancer 48: 405–410.

  • Metzstein MM, Stanfield GM and Horvitz HR. . 1998 Trends Genet. 14: 410–416.

  • Mignotte B and Vayssière J-L. . 1998 Eur. J. Biochem. 252: 1–15.

  • Miwa K, Asano M, Horai R, Iwakura Y, Nagata S and Suda T. . 1998 Nat. Med. 4: 1287–1292.

  • Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD, Klionsky DJ, Ohsumi M and Ohsumi Y. . 1998 Nature 395: 395–398.

  • Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M and Krammer PH. . 1998 J. Exp. Med. 188: 2033–2045.

  • Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM. . 1996 Cell 85: 817–827.

  • Nagata S. . 1997 Cell 88: 355–365.

  • Neale ML, Fiera RA and Matthews N. . 1988 Immunology 64: 81–85.

  • Nishina H, Radvanyi L, Raju K, Sasaki T, Kozieradzki I and Penninger JM. . 1998 J. Immunol. 161: 3416–3420.

  • Nishina H, Vaz C, Billia P, Nghiem M, Sasaki T, De la Pompa JL, Furlonger K, Paige C, Hui C, Fischer K-D, Kishimoto H, Iwatsubo T, Katada T, Woodgett JR and Penninger JM. . 1999 Development 126: 505–516.

  • Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K and Ichijo H. . 1998 Mol. Cell 2: 389–395.

  • Pan G, O'Rourke K and Dixit VM. . 1998 J. Biol. Chem. 273: 5841–5845.

  • Park YM, Anderson RL, Spitz DR and Hahn GM. . 1992 Radiat. Res. 131: 162–168.

  • Pasinelli P, Borchelt DR, Houseweart MK, Cleveland DW and Brown Jr RH. . 1998 Proc. Natl. Acad. Sci. USA 95: 15763–15768.

  • Peppelenbosch M, Boone E, Jones GE, van Deventer SJH, Haegeman G, Fiers W, Grooten J and Ridley AJ. . 1999 J. Immunol. 162: 837–845.

  • Prins JB, Ledgerwood EC, Ameloot P, Vandenabeele P, Faraco PR, Bright NA, O'Rahilly S and Bradley JR. . 1998 Biosci. Rep. 18: 329–340.

  • Raff MC. . 1992 Nature 356: 397–400.

  • Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM and Venkatachalam MA. . 1998a Oncogene 17: 3401–3415.

  • Saikumar P, Dong Z, Weinberg JM and Venkatachalam MA. . 1998b Oncogene 17: 3341–3349.

  • Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K and Ichijo H. . 1998 EMBO J. 17: 2596–2606.

  • Salvesen GS and Dixit VM. . 1999 Proc. Natl. Acad. Sci. USA 96: 10964–10967.

  • Samali A, Cai J, Zhivotovsky B, Jones DP and Orrenius S. . 1999 EMBO J. 18: 2040–2048.

  • Sanchez-Perez I, Murguia JR and Perona R. . 1998 Oncogene 16: 533–540.

  • Sánchez-Alcázar JA, Ruíz-Cabello J, Hernández-Muñoz I, Sánchez-Pobre P, de la Torre P, Siles-Rivas E, García I, Kaplan O, Muñoz-Yagüe MT and Solís-Herruzo JA. . 1997 J. Biol. Chem. 272: 30167–30177.

  • Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH and Peter ME. . 1998 EMBO J. 17: 1675–1687.

  • Schweichel JU and Merker HJ. . 1973 Teratology 7: 253–266.

  • Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA and Fiers W. . 1992 J. Biol. Chem. 267: 5317–5323.

  • Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G and Fiers W. . 1993 EMBO J. 12: 3095–3104.

  • Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S and Peter ME. . 1998 Eur. J. Biochem. 254: 439–459.

  • Shimizu S, Narita M and Tsujimoto Y. . 1999 Nature 399: 483–487.

  • Shinoura N, Yoshida Y, Asai A, Kirino T and Hamada H. . 1999 Oncogene 18: 5703–5713.

  • Sidoti-de Fraisse C, Rincheval V, Risler Y, Mignotte B and Vayssière J-L. . 1998 Oncogene 17: 1639–1651.

  • Simm A, Bertsch G, Frank H, Zimmermann U and Hoppe J. . 1997 J. Cell Sci. 110: 819–828.

  • Singh A, Ni J and Aggarwal BB. . 1998 J. Interferon Cytokine Res. 18: 439–450.

  • Single B, Leist M and Nicotera P. . 1998 Cell Death Differ. 5: 1001–1003.

  • Slater AFG, Stefan C, Nobel I, van den Dobbelsteen DJ and Orrenius S. . 1995 Toxicol. Lett. 82: 149–153.

  • Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ. . 1999 J. Cell Biol. 144: 281–292.

  • Srinivasula SM, Ahmad M, Fernandes-Alnemri T and Alnemri ES. . 1998 Mol. Cell 1: 949–957.

  • Steemans M, Goossens V, Van de Craen M, Van Herreweghe F, Vancompernolle K, De Vos K, Vandenabeele P and Grooten J. . 1998 J. Exp. Med. 188: 2193–2198.

  • Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM and Salvesen GS. . 1999 J. Biol. Chem. 274: 8359–8362.

  • Stridh H, Kimland M, Jones DP, Orrenius S and Hampton MB. . 1998 FEBS Lett. 429: 351–355.

  • Stroh C and Schulze-Osthoff K. . 1998 Cell Death Differ. 5: 997–1000.

  • Suffys P, Beyaert R, Van Roy F and Fiers W. . 1988 Eur. J. Biochem. 178: 257–265.

  • Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino Jr MA and Shepard HM. . 1985 Science 230: 943–945.

  • Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM and Kroemer G. . 1999 Nature 397: 441–446.

  • Tanaka M, Itai T, Adachi M and Nagata S. . 1998 Nat. Med. 4: 31–36.

  • Taniguchi S, Furukawa M, Kono T, Hisa T, Ishii M and Hamada T. . 1996 J. Dermatol. Sci. 12: 44–49.

  • Tartaglia LA, Ayres TM, Wong GHW and Goeddel DV. . 1993 Cell 74: 845–853.

  • Tewari M and Dixit VM. . 1995 J. Biol. Chem. 270: 3255–3260.

  • Thornberry NA and Lazebnik Y. . 1998 Science 281: 1312–1316.

  • Tschopp J, Martinon F and Hofmann K. . 1999 Curr. Biol. 9: R381–R384.

  • Ueda S, Nakamura H, Masutani H, Sasada T, Yonehara S, Takabayashi A, Yamaoka Y and Yodoi J. . 1998 J. Immunol. 161: 6689–6695.

  • Van de Craen M, Declercq W, Van den brande I, Fiers W and Vandenabeele P. . 1999 Cell Death Differ. 6, in press.

  • Vander Heiden MG, Chandel NS, Schumacker PT and Thompson CB. . 1999 Mol. Cell 3: 159–167.

  • Vandevoorde V, Haegeman G and Fiers W. . 1997 J. Cell Biol. 137: 1627–1638.

  • Vanhaesebroeck B, Mareel M, Van Roy F, Grooten J and Fiers W. . 1991 Cancer Res. 51: 2229–2238.

  • Vaux DL and Korsmeyer SJ. . 1999 Cell 96: 245–254.

  • Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W and Vandenabeele P. . 1998a J. Exp. Med. 187: 1477–1485.

  • Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W and Vandenabeele P. . 1998b J. Exp. Med. 188: 919–930.

  • Vercammen D, Vandenabeele P, Beyaert R, Declercq W and Fiers W. . 1997 Cytokine 9: 801–808.

  • Vogt M, Bauer MKA, Ferrari D and Schulze-Osthoff K. . 1998 FEBS Lett. 429: 67–72.

  • Wallach D, Boldin MP, Kovalenko AV, Malinin NL, Mett IL and Camonis JH. . 1998 Curr. Opin. Immunol. 10: 131–136.

  • Wang C, Cusack Jr JC, Liu R and Baldwin Jr AS. . 1999 Nat. Med. 5: 412–417.

  • Wang C, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS. . 1998a Science 281: 1680–1683.

  • Wang T, Wang H, Ichijo H, Giannakakou P, Foster JS, Fojo T and Wimalasena J. . 1998b J. Biol. Chem. 273: 4928–4936.

  • Warner BB, Stuart L, Gebb S and Wispe JR. . 1996 Am. J. Physiol. 271: L150–L158.

  • Wisdom R, Johnson RS and Moore C. . 1999 EMBO J. 18: 188–197.

  • Wong GHW. . 1995 Biochim. Biophys. Acta 1271: 205–209.

  • Wong GHW, Elwell JH, Oberley LW and Goeddel DV. . 1989 Cell 58: 923–931.

  • Xu Y, Krishnan A, Wan XS, Majima H, Yeh C, Ludewig G, Kasarskis EJ and St.Clair DK. . 1999 Oncogene 18: 93–102.

  • Yang X, Chang HY and Baltimore D. (1998). . Science 281: 1355–1357.

  • Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV and Mak TW. . 1997 Immunity 7: 715–725.

  • Yin X, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA and Korsmeyer SJ. . 1999 Nature 400: 886–891.

  • Yoshida H, Kong Y, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM and Mak TW. . 1998 Cell 94: 739–750.

  • Zhang P, Liu B, Kang SW, Seo MS, Rhee SG and Obeid LM. . 1997 J. Biol. Chem. 272: 30615–30618.

  • Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM and Salvesen GS. . 1997 J. Biol. Chem. 272: 7797–7800.

Download references

Acknowledgements

R Beyaert is a postdoctoral researcher and P Vandenabeele is a research associate with the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fiers, W., Beyaert, R., Declercq, W. et al. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719–7730 (1999). https://doi.org/10.1038/sj.onc.1203249

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203249

Keywords

This article is cited by

Search

Quick links